Discover how AI is revolutionizing biotech in this engaging episode with Karl Schmieder, CEO and Founder of Messaginglab. Karl, who has a background in biochemistry and creative writing, brings a unique perspective, emphasizing the power of storytelling in biotech. Please visit our website to get more information: https://swangroup.net/ In this episode, Karl discusses the importance of data standardization, the role of AI in analyzing Electronic Medical Records (EMR) and Electronic Health Records (EHR), and the growth of the biotech industry. Learn how networking and effective communication can bridge gaps between startups, investors, and the public.The conversation spans data standardization, the need for structured datasets for efficient AI analysis, and the potential for AI to glean insights from Electronic Medical Records (EMR) and Electronic Health Records (EHR). Karl also illuminates the biotech industry's recent growth, noting the significance of networking and effective communication in bridging gaps between startups, investors, and the broader public. Specifically, this episode highlights the following themes:Encouraging a culture of innovation and trustThe intersection of technology and practical applicationThe future of organ manufacturing and its impactLinks from this episode:Get to know more about Karl Schmieder:https://www.linkedin.com/in/karlschmiederLearn more about Messaginglab: https://www.messaginglab.comGet in Touch with Karl Schmieder: [email protected]/646-515-3392Get to know more about Steven Swan: https://www.linkedin.com/in/swangroupWatch now for insights on:Innovation and trust in biotechThe practical application of technologyThe future impact of organ manufacturingThis video is about How AI Is Transforming Biotech: Expert Talk With Karl Schmieder! But It also covers the following topics:AI Data Analysis In BiotechKarl Schmieder Biotech InsightsRole Of AI In Medical RecordsVideo Title: How AI Is Transforming Biotech: Expert Talk With Karl Schmieder! 🔔 Stay ahead in biotech and pharma! Subscribe for exclusive industry trends, leader insights, industry leader interviews, best practices, and innovative biotech strategies!https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1 🔗 Stay Connected With Us.👉 Linkedin: https://www.linkedin.com/company/the-swan-group/ 👉 Website: https://swangroup.net/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related